1832 Asset Management
AGN

1832 Asset Management’s Allergan plc AGN Stock Holding History

1832 Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-743,554
Closed -$124M – 788
2019
Q2 		$124M Sell
743,554
-248,557
-25% -$34.4M 0.4% 68
2019
Q1 		$146M Buy
992,111
+13,700
+1% +$1.99M 0.5% 56
2018
Q4 		$131M Sell
978,411
-61,500
-6% -$10.1M 0.52% 52
2018
Q3 		$198M Sell
1,039,911
-177,863
-15% -$32.7M 0.65% 41
2018
Q2 		$203M Sell
1,217,774
-293,822
-19% -$47.2M 0.69% 42
2018
Q1 		$256M Sell
1,511,596
-159,889
-10% -$26.8M 0.94% 33
2017
Q4 		$272M Buy
1,671,485
+213,895
+15% +$38.4M 0.88% 35
2017
Q3 		$290M Buy
1,457,590
+309,343
+27% +$71.9M 1.01% 28
2017
Q2 		$279M Buy
1,148,247
+164,379
+17% +$38.6M 1.26% 20
2017
Q1 		$236M Buy
983,868
+522,777
+113% +$122M 0.84% 33
2016
Q4 		$96.8M Buy
461,091
+458,779
+19,843% +$95M 0.3% 94
2016
Q3 		$532K Sell
2,312
-9,319
-80% -$2.28M ﹤0.01% 475
2016
Q2 		$2.68M Sell
11,631
-658,934
-98% -$152M 0.01% 347
2016
Q1 		$310M Buy
670,565
+322,020
+92% +$92.2M 0.76% 37
2015
Q4 		$110M Buy
348,545
+87,320
+33% +$26M 0.48% 60
2015
Q3 		$71.2M Buy
261,225
+10,840
+4% +$3.33M 0.3% 81
2015
Q2 		$75.9M Sell
250,385
-60,675
-20% -$18.1M 0.26% 93
2015
Q1 		$92.7M Sell
311,060
-21,260
-6% -$6.06M 0.35% 77
2014
Q4 		$85.1M Buy
332,320
+35,975
+12% +$8.99M 0.26% 91
2014
Q3 		$71.4M Buy
296,345
+33,655
+13% +$7.53M 0.23% 111
2014
Q2 		$58.5M Buy
262,690
+37,598
+17% +$7.78M 0.18% 137
2014
Q1 		$45.8M Buy
225,092
+200,760
+825% +$39.8M 0.16% 140
2013
Q4 		$4.09M Buy
+24,332
New +$3.8M 0.02% 317

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

1832 Asset Management's AGN Position: Q3 2019 in Review

1832 Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 743,554 shares — an estimated $124M sold.

1832 Asset Management first reported a position in AGN in Q4 2013 and held it in 23 quarters. The position peaked at $310M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • 1832 Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • 1832 Asset Management sold 743,554 Allergan plc shares in Q3 2019, an estimated $124M.
  • 1832 Asset Management first reported a position in Allergan plc in Q4 2013 and held it in 23 quarters.
  • 1832 Asset Management's Allergan plc position peaked at $310M in Q1 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on 1832 Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.